终末期肾衰竭患者铝过载的诊断与治疗 - Suppr | 超能文献

终末期肾衰竭患者铝过载的诊断与治疗 - Suppr | 超能文献

相似文献

1

Diagnosis and treatment of aluminium overload in end-stage renal failure patients.终末期肾衰竭患者铝过载的诊断与治疗

Nephrol Dial Transplant. 1993;8 Suppl 1:1-4.

2

Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Consensus conference. Paris, France, 27 June 1992.

Nephrol Dial Transplant. 1993;8 Suppl 1:1-54.

3

[Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].

Nephrologie. 1986;7(5):177-80.

4

[Successful treatment of progressive dialysis encephalopathy. Case report].[成功治疗进行性透析性脑病。病例报告]

Z Urol Nephrol. 1985 Jul;78(7):387-93.

5

Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.慢性肾衰竭中的脑病对去铁胺治疗有反应。铝神经毒性的另一种表现。

Arch Intern Med. 1986 Oct;146(10):2063-4.

6

Drugs as a hidden source of aluminium for chronic renal patients.药物作为慢性肾病患者铝的隐匿来源。

Nephrol Dial Transplant. 2007 Feb;22(2):605-11. doi: 10.1093/ndt/gfl569. Epub 2006 Oct 11.

7

[Aluminum and iron deposition in dialysis patients].

Nihon Rinsho. 1992 Jan;50 Suppl:905-10.

8

Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.铝骨病的间接诊断方法：血浆铝、去铁胺输注试验和血清iPTH。

Kidney Int Suppl. 1986 Feb;18:S96-9.

9

Prevention and treatment of aluminum intoxication in chronic renal failure.慢性肾衰竭中铝中毒的防治

Adv Nephrol Necker Hosp. 1985;14:439-78.

10

The efficacy of various treatment modalities on aluminium associated bone disease.

Proc Eur Dial Transplant Assoc. 1983;19:195-202.

引用本文的文献

1

Efficacy of low-dose desferrioxamine for the estimation of aluminium overload in haemodialysis patients.低剂量去铁胺对血液透析患者铝过载评估的疗效

Pharm World Sci. 1996 Oct;18(5):187-91. doi: 10.1007/BF00820731.